Pro-Dex stock analysis: powered surgical instruments maker with heavy customer concentration risk. Read here for more on PDEX ...

Argan (AGX) rides surging US power demand with a $3B backlog and strong debt-free financials—yet looks overvalued. See more ...

Biotech innovator Alumis, focused on autoimmune therapies, reported a significant insider buy amid a year of robust stock ...

Prediction market apps are thriving in Trump's second term, with traders betting on migrant deportations to election outcomes. A community of young, mostly male and very online traders are driving the ...